- Home
- CISS vs EDVA Comparison
CISS vs EDVA Comparison
Compare CISS & EDVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CISS | EDVA |
|---|---|---|
| Founded | 2022 | N/A |
| Country | Greece | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Beverages (Production/Distribution) |
| Sector | Consumer Discretionary | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3M | 1.2M |
| IPO Year | 2022 | 2012 |
Fundamental Metrics
Financial Performance| Metric | CISS | EDVA |
|---|---|---|
| Price | $0.80 | $0.16 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 566.7K | ★ 1.9M |
| Earning Date | 11-17-2026 | 08-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 32.30 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $73,066.00 |
| Revenue This Year | N/A | $24,377.87 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $0.82 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.06 | $0.15 |
| 52 Week High | $6.06 | $0.32 |
Technical Indicators
Market Signals| Indicator | CISS | EDVA |
|---|---|---|
| Relative Strength Index (RSI) | 34.62 | 22.70 |
| Support Level | $0.76 | N/A |
| Resistance Level | $0.88 | $0.18 |
| Average True Range (ATR) | 0.14 | 0.03 |
| MACD | -0.04 | -0.00 |
| Stochastic Oscillator | 1.58 | 7.39 |
Price Performance
Historical ComparisonAbout CISS C3is Inc.
C3is Inc is a provider of international seaborne transportation services to dry bulk charterers, including national and private industrial users, commodity producers, and traders. The company owns and operates a fleet of two dry bulk carriers that transport bulk commodities such as iron ore, coal, and grains, and minor bulks such as bauxite, phosphate, and fertilizers.
About EDVA Endovia Health Sciences Inc. Common Stock
Endovia Health Sciences Inc is building a diversified cannabinoid health sciences platform through pharmaceutical innovation, strategic partnerships and disciplined execution. Endovia acquires, develops and commercializes differentiated cannabinoid health technologies across pharmaceutical, veterinary and consumer wellness markets. Endovia's product begins with CannEpil, a cannabinoid pharmaceutical asset, and extends into veterinary development and consumer wellness as the pipeline expands.